StaphVAX in Cardiovascular Surgery Patients

NCT00211913 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Infections
Cardiovascular Diseases
Cardiovascular Surgical Procedures

Interventions

BIOLOGICAL: S. aureus Type 5 & 8 Capsular Polysaccharide Conjugate
BIOLOGICAL: placebo

Sponsor

Nabi Biopharmaceuticals